Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

65 66 Next >

5 Investors Betting Big on Novavax (NVAX) Stock ↗

October 11, 2022

NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug.

Via InvestorPlace

Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway ↗

October 11, 2022

Today, investors in Novavax and NVAX stock are cheering the start of a major conference on vaccine tech, which Novavax is a part of.

Via InvestorPlace

What's Going On With Novavax Shares? ↗

October 11, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 11.4% to $19.80 Tuesday afternoon ahead of the company's presentation of data at the World Vaccine Congress Europe 2022 this week. What Else?

Via Benzinga

Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down' ↗

October 11, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down."

Via Benzinga

Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11 ↗

October 10, 2022

Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data.

Via InvestorPlace

Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday ↗

October 10, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session.

Via Benzinga

Why Novavax Stock Is Jumping Today ↗

October 10, 2022

The company reported positive developments in Switzerland and South Korea.

Via The Motley Fool

A Shot of NVAX Stock Is NOT What Your Portfolio Needs ↗

September 28, 2022

Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots.

Via InvestorPlace

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Swiss Health Agency Approves Pfizer, Novavax's Omicron Adapted COVID-19 Boosters ↗

October 10, 2022

Via Benzinga

Novavax Says Initial 1M Doses Of Nuvaxovid COVID-19 Vaccine Are Available In UK ↗

September 27, 2022

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

Ryder System, Harrow Health And Other Big Gainers From Tuesday ↗

September 28, 2022

U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 27, 2022

Gainers

Via Benzinga

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’ ↗

September 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

Via InvestorPlace

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday ↗

September 27, 2022

Gainers

Via Benzinga

MarketBeat: Week in Review 9/19 – 9/23

September 24, 2022

The sell-off in the market confirms that the global economy is slowing. What should you do? Here are some insights our analysts delivered for you this week

Via MarketBeat

Topics Economy

Pharma Giants Moderna And Novavax Trend Lower In This Pattern: What's Going On? ↗

September 23, 2022

Moderna Inc. (NASDAQ: MRNA) and Novavax Inc. (NASDAQ: NVAX) were trading down over 2% and 4%, respectively in the premarket Friday despite both stocks showing signs a bounce could be in the cards.

Via Benzinga

KB Home, Darden Restaurants And Other Big Losers From Thursday ↗

September 23, 2022

U.S. stocks closed lower with the Dow Jones dropping more than 100 points on Thursday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 22, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak ↗

September 22, 2022

In the U.S., Novavax is going after the 10% of unvaccinated adults.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022 ↗

September 22, 2022

Upgrades

Via Benzinga

What Is Going on With Accenture (ACN) Stock Today? ↗

September 22, 2022

Accenture (ACN) stock is on the move Thursday after releasing a positive earnings report and announcing a new acquisition.

Via InvestorPlace

Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE ↗

September 22, 2022

Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday.

Via Benzinga

Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement ↗

September 22, 2022

Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK).

Via InvestorPlace

Why Is Novavax (NVAX) Stock Falling Today? ↗

September 22, 2022

Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.

Via InvestorPlace

Why Novavax Stock Is Trading Lower Today ↗

September 22, 2022

Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following bearish analyst coverage from JPMorgan.

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today